https://www.pcctc.org/https://www.pcctc.org/about/https://www.pcctc.org/expertise/https://www.pcctc.org/guidingprinciples/https://www.pcctc.org/news/https://www.pcctc.org/news/6th-annual-nyc-prostate-cancer-summit-to-feature-pcctc-investigators/https://www.pcctc.org/news/2026-summer-internship-program/https://www.pcctc.org/news/acs-trial-library/https://www.pcctc.org/news/advancing-the-standard-how-the-pcctc-led-the-science-at-the-2026-asco-gu-symposium-and-forged-new-paths-for-collaboration/https://www.pcctc.org/news/caris-life-sciences-pcctc-and-sorrento-therapeutics-announce-collaboration-to-advance-precision-medicine-development-using-comprehensive-genomic-profiling/https://www.pcctc.org/news/cdmrp-features-pcctc-managed-promise-registry/https://www.pcctc.org/news/cellcentric-signs-agreement-with-the-pcctc-for-phase-ii-clinical-trial-expansion-into-the-us/https://www.pcctc.org/news/dr-howard-i-scher-honored-with-richard-d-williams-md-prostate-cancer-research-excellence-award/https://www.pcctc.org/news/dr-sean-mcbride-on-the-pcctc-managed-aasur-trial-in-high-risk-prostate-cancer/https://www.pcctc.org/news/esmo-2024-cc-94676-pca-001-clinical-activity-of-bms-986365-a-dual-androgen-receptor-ligand-directed-degrader-and-antagonist-in-heavily-pretreated-patients-with-mcrpc/https://www.pcctc.org/news/first-patient-enrolled-at-memorial-sloan-kettering-cancer-center-in-pcctc-sponsored-talent-study-evaluating-novel-treatment-combination-for-advanced-prostate-cancer/https://www.pcctc.org/news/first-quadruplet-therapy-regimen-shows-promise-for-men-with-high-volume-metastatic-apmn-prostate-cancer/https://www.pcctc.org/news/g46w73q8mx5oy5ql00h9njfkp166fn/https://www.pcctc.org/news/just-published-recruitment-strategies-in-the-pcctc-managed-promise-registry/https://www.pcctc.org/news/k36-therapeutics-completes-dosing-of-first-cohort-in-pcctc-managed-phase-1-clinical-trial-of-ktx-2001-in-prostate-cancer/https://www.pcctc.org/news/landmark-prostate-cancer-trial-shows-combination-therapy-more-than-doubles-survival-in-metastatic-castration-resistant-prostate-cancer-patients-with-dna-repair-defects/https://www.pcctc.org/news/lantheus-collaborates-with-the-pcctc-to-advance-ai-enabled-imaging-biomarkers-in-prostate-cancer/https://www.pcctc.org/news/lej11atqrj9rsuh3s89sv1rxat999o/https://www.pcctc.org/news/oncoc4-announces-first-patient-with-advanced-prostate-cancer-dosed-in-phase-12-trial-of-biontech-partnered-bnt316onc-392-program/https://www.pcctc.org/news/pcctc-innovation-featured-at-biocom-californias-innovations-in-oncology-clinical-trial-design-forum/https://www.pcctc.org/news/pcctc-investigator-andrew-j-armstrong-md-ms-selected-for-rapid-oral-abstract-session-at-2026-asco-annual-meeting/https://www.pcctc.org/news/pcctc-investigator-dr-andrew-armstrong-on-pcwg4s-amended-terminology-and-biomarker-standards-for-advanced-prostate-ccancer/https://www.pcctc.org/news/pcctc-investigator-dr-rana-mckay-wins-the-2024-christopher-g-wood-rising-star-award-at-ikcs-europe/https://www.pcctc.org/news/pcctc-investigators-and-colleagues-highlight-the-importance-of-racial-diversity-in-future-genomic-profiling-and-clinical-trials-efforts-nature/https://www.pcctc.org/news/pcctc-investigators-on-the-diversity-of-enrollment-in-prostate-cancer-clinical-trials/https://www.pcctc.org/news/pcctc-investigators-present-an-impressive-and-diverse-slate-of-abstracts-at-asco-2026/https://www.pcctc.org/news/pcctc-investigators-showcase-groundbreaking-research-at-2026-asco-gu-symposium/https://www.pcctc.org/news/pcctc-managed-phase-1-study-of-k36s-novel-nsd2-inhibitor-ktx-2001-activated/https://www.pcctc.org/news/pcctc-scientific-oversight-committee-chair-reflects-on-advances-made-in-high-risk-low-grade-prostate-cancer-management/https://www.pcctc.org/news/pcctc-trial-is-first-to-use-standard-ra-223-doses-contemporary-pain-endpoints-and-pro-collection-tools/https://www.pcctc.org/news/prognostic-significance-of-psagt02-after-6-12-months-treatment-for-mhspc-intensified-by-arpis-a-multinational-real-world-analysis-of-the-ironman-registry/https://www.pcctc.org/news/prostate-cancer-working-group-4-publishes-landmark-recommendations-in-the-journal-of-clinical-oncology/https://www.pcctc.org/news/prostate-cancer-working-group-4-unveils-updated-global-standards-for-advanced-prostate-cancer-clinical-trials-at-2026-asco-gu-symposium/https://www.pcctc.org/news/results-from-cohorts-4-and-5-of-the-phase-2-keynote-199-study-published/https://www.pcctc.org/news/results-from-the-pcctc-managed-abiraterone-olaparib-or-abiraterone-olaparib-in-first-line-mcrpc-with-dna-repair-defects-brcaaway-study-published-in-clinical-cancer-research/https://www.pcctc.org/news/results-from-the-pcctcs-randomized-phase-2-trial-of-abiraterone-acetate-with-or-without-cabazitaxel-published-in-the-journal-of-clinical-oncology/https://www.pcctc.org/news/results-from-the-pcctcs-stream-study-led-by-rhonda-l-bitting-md-of-duke-university-published/https://www.pcctc.org/news/summer-internships-announced/https://www.pcctc.org/news/t43d6lz3w1wu08mdmkvb13hujs2gnw/https://www.pcctc.org/news/tackling-diversity-in-prostate-cancer-clinical-trials-a-report-from-the-diversity-working-group-of-the-ironman-registry/https://www.pcctc.org/news/the-pcctc-at-asco-2025/https://www.pcctc.org/news/the-pcctc-at-asco-gu-2025/https://www.pcctc.org/news/the-pcctc-at-ses-aua-2025-phase-1-trial-of-mevrometostat-pf-06821497-a-potent-and-selective-inhibitor-of-ezh2-in-crpc/https://www.pcctc.org/news/the-pcctc-germline-genetics-working-group-publishes-new-guidelines/https://www.pcctc.org/news/the-pcctc-managed-ironman-registry-deepens-the-understanding-of-racial-disparities-in-pain-and-survival-in-individuals-with-advanced-prostate-cancer/https://www.pcctc.org/news/the-pcctc-managed-promise-registry-manuscript-published-in-the-prostate/https://www.pcctc.org/news/the-pcctcs-study-of-talazoparib-with-or-without-enzalutamide-in-people-with-prostate-cancer-who-have-previously-received-abiraterone-acetate-talent-activated/https://www.pcctc.org/news/the-prostate-cancer-clinical-trials-consortium-pcctc-receives-gift-from-friends-and-family-against-prostate-cancer/https://www.pcctc.org/news/the-transformative-development-and-progress-of-the-pcctc/https://www.pcctc.org/news/xtuwfplfpdk6vtzc0w21azsourjv3w/https://www.pcctc.org/services/https://www.pcctc.org/studies/https://www.pcctc.org/talent/https://www.pcctc.org/workinggroups/